BR112013027125A2 - método e sistema para analisar características de tecido, e, kit - Google Patents

método e sistema para analisar características de tecido, e, kit

Info

Publication number
BR112013027125A2
BR112013027125A2 BR112013027125A BR112013027125A BR112013027125A2 BR 112013027125 A2 BR112013027125 A2 BR 112013027125A2 BR 112013027125 A BR112013027125 A BR 112013027125A BR 112013027125 A BR112013027125 A BR 112013027125A BR 112013027125 A2 BR112013027125 A2 BR 112013027125A2
Authority
BR
Brazil
Prior art keywords
cell
kit
tissue characteristics
biomarkers
profile data
Prior art date
Application number
BR112013027125A
Other languages
English (en)
Portuguese (pt)
Inventor
Christopher James Sevinsky
Colin Craig Mcculloch
Fiona Ginty
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of BR112013027125A2 publication Critical patent/BR112013027125A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211—Selection of the most significant subset of features
    • G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/771—Feature selection, e.g. selecting representative features from a multi-dimensional feature space
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698—Matching; Classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Multimedia (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Medical Informatics (AREA)
  • Software Systems (AREA)
  • Evolutionary Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Computing Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112013027125A 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit BR112013027125A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US13/252,069 US20120270752A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,078 US20120269419A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
PCT/EP2012/057387 WO2012143556A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments

Publications (1)

Publication Number Publication Date
BR112013027125A2 true BR112013027125A2 (pt) 2017-01-10

Family

ID=47021377

Family Applications (4)

Application Number Title Priority Date Filing Date
BR112013027125A BR112013027125A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027122A BR112013027122A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido

Family Applications After (3)

Application Number Title Priority Date Filing Date
BR112013027122A BR112013027122A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido

Country Status (8)

Country Link
US (5) US20120269418A1 (https=)
EP (4) EP2700038B1 (https=)
JP (4) JP6063446B2 (https=)
BR (4) BR112013027125A2 (https=)
CA (4) CA2833428A1 (https=)
RU (3) RU2013145151A (https=)
SG (4) SG194594A1 (https=)
WO (4) WO2012143556A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
WO2014089494A1 (en) * 2012-12-06 2014-06-12 Clarient Diagnostic Services, Inc. Systems and methods for split screen display of a biological specimen and for capturing records thereof
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) * 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
WO2015003178A1 (en) * 2013-07-03 2015-01-08 Coyne Scientific, Llc Methods for predicting responses to chemical or biologic substances
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
CA2971129A1 (en) 2015-01-22 2016-07-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for determining proportions of distinct cell subsets
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
WO2017109860A1 (ja) * 2015-12-22 2017-06-29 株式会社ニコン 画像処理装置
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
WO2018094113A1 (en) * 2016-11-16 2018-05-24 University Of Washington Systems and methods for cyclic fluorescence imaging
US11042551B2 (en) * 2016-12-02 2021-06-22 Fair Isaac Corporation Fast automatic explanation of scored observations
US11436719B2 (en) 2017-02-16 2022-09-06 Kyoto University Cell evaluation method, cell evaluation device, and recording medium storing cell evaluation program
US10127696B2 (en) * 2017-03-22 2018-11-13 Sas Institute Inc. Computer system to generate scalable plots using clustering
US10535434B2 (en) * 2017-04-28 2020-01-14 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
EP3655955B1 (en) 2017-07-21 2025-04-09 The Board of Trustees of the Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
US10706328B2 (en) 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
WO2020056372A1 (en) * 2018-09-14 2020-03-19 Krishnan Ramanathan Multimodal learning framework for analysis of clinical trials
US11101043B2 (en) 2018-09-24 2021-08-24 Zasti Inc. Hybrid analysis framework for prediction of outcomes in clinical trials
SG11202105063QA (en) * 2018-11-29 2021-06-29 Somalogic Inc Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
JP7368679B2 (ja) * 2021-09-01 2023-10-25 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
IT202200001817A1 (it) 2022-02-02 2023-08-02 Aizoon S R L Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico
IT202200005861A1 (it) 2022-03-24 2023-09-24 Aizoon S R L Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico
US20240028964A1 (en) 2022-07-25 2024-01-25 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product
WO2025258375A1 (ja) * 2024-06-12 2025-12-18 ソニーグループ株式会社 情報処理方法及び情報処理システム

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
JP2005503760A (ja) * 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
AU2003255332A1 (en) * 2002-07-30 2004-02-23 Steinbeis-Transferzentrum Analytische Elektronenmikroskopie, Biomedizin, Biotechnologie-Heidelberg Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
EP1872124A4 (en) * 2005-04-19 2008-06-11 Prediction Sciences Llc DIAGNOSIS MARKET FOR BREAST CANCER TREATMENT AND PROGRESSION AND METHOD OF USE THEREOF
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
EP2027465A2 (en) * 2006-05-17 2009-02-25 Cellumen, Inc. Method for automated tissue analysis
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
AU2008231393A1 (en) * 2007-03-27 2008-10-02 Rosetta Genomics Ltd. Gene expression signature for classification of cancers
JP2010527007A (ja) * 2007-05-07 2010-08-05 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 細胞アッセイ及び組織の自動解析のためのシステム及び方法
CA2690612C (en) * 2007-05-14 2016-07-05 Historx, Inc. Compartment segregation by pixel characterization using image data clustering
JP2010538609A (ja) * 2007-09-06 2010-12-16 バイオセラノスティクス，インコーポレイティド 腫瘍グレード分類と癌の予後診断
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
PT2332087T (pt) * 2008-07-25 2020-06-05 Fund D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud Sistemas e métodos de tratamento, diagnóstico e previsão da ocorrência de uma condição médica
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8320655B2 (en) 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Also Published As

Publication number Publication date
RU2013145162A (ru) 2015-05-27
RU2013145154A (ru) 2015-05-27
WO2012143561A3 (en) 2013-05-23
JP6163152B2 (ja) 2017-07-12
CA2833497A1 (en) 2012-10-26
WO2012143562A3 (en) 2013-02-28
WO2012143558A2 (en) 2012-10-26
EP2700037A2 (en) 2014-02-26
WO2012143556A2 (en) 2012-10-26
WO2012143558A3 (en) 2012-12-20
WO2012143562A2 (en) 2012-10-26
WO2012143556A3 (en) 2013-05-30
EP2700042A2 (en) 2014-02-26
US20120269419A1 (en) 2012-10-25
EP2700038A2 (en) 2014-02-26
JP2014516413A (ja) 2014-07-10
US20120271553A1 (en) 2012-10-25
EP2700042B1 (en) 2021-03-17
WO2012143561A2 (en) 2012-10-26
SG194594A1 (en) 2013-12-30
CA2833804A1 (en) 2012-10-26
JP6063446B2 (ja) 2017-01-18
SG194592A1 (en) 2013-12-30
SG194588A1 (en) 2013-12-30
JP6143743B2 (ja) 2017-06-07
JP6063447B2 (ja) 2017-01-18
JP2014521925A (ja) 2014-08-28
BR112013027122A2 (pt) 2017-01-10
CA2833428A1 (en) 2012-10-26
US20140185905A1 (en) 2014-07-03
BR112013027124A2 (pt) 2017-01-10
US20120270752A1 (en) 2012-10-25
JP2014517954A (ja) 2014-07-24
EP2700036A2 (en) 2014-02-26
BR112013027123A2 (pt) 2017-01-10
US20120269418A1 (en) 2012-10-25
SG194590A1 (en) 2013-12-30
RU2013145151A (ru) 2015-05-27
CA2833295A1 (en) 2012-10-26
JP2014521926A (ja) 2014-08-28
EP2700038B1 (en) 2021-04-21

Similar Documents

Publication Publication Date Title
BR112013027125A2 (pt) método e sistema para analisar características de tecido, e, kit
Eckstein et al. Imaging research results from the Osteoarthritis Initiative (OAI): a review and lessons learned 10 years after start of enrolment
BR112016006097A2 (pt) técnicas de análise de imagem para o diagnóstico de doenças
ES2656962T3 (es) Métodos para evaluar la receptividad del endometrio de una paciente
BR112015015131A2 (pt) método, aparelho, mídia de armazenamento não transitório, programa de computador, e produto
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
JP2014517954A5 (https=)
BR112018070971A2 (pt) métodos e kits para a diagnose e estratificação de risco de pacientes com isquemia
HK1201180A1 (en) Method and system for analyzing biological specimens by spectral imaging
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
CN110392740A (zh) 确定人群样本生物指标集、预测生物学年龄的方法及其应用
BR112012032205A2 (pt) método, aparelhos e meio de armazenamento legível por computador para avaliar uma condição fisica de um paciente.
WO2014198670A3 (en) Methods of viewing and analyzing high content biological data
Cai et al. Clinical features and gut microbiota alterations in hypertensive individuals with left ventricular hypertrophy
LI et al. Expression of long non-coding RNA H19 in serum in patients with acute pancreatitis and its clinical significance
LIANG et al. Correlation between CD8+ T cells' balance and prognosis for patients with diffuse axonal injury
LIN et al. Serum Biochemical Markers for Early Prediction of Severity of Acute Pancreatitis
XIA The relationship of serum miR-30a and heart failure in children with congenital heart disease
YANG et al. Multivariate analysis of chondrosarcoma prognosis
LU et al. Influence factors of the timing of endoscopic examination in nonvariceal upper gastrointestinal bleeding
FU et al. The value of PCT, CRP, TNF-α and free DNA in predicting the development of MODS in patients with multiple trauma
全以祖 et al. Interstitial Lung Disease in Polymyositis/dermatomyositis: Association between the Onset of Interstitial Lung Disease and Clinical Outcome
Sayer et al. Troponin assessment in heart failure with preserved ejection fraction: time to get with the guidelines
ZHOU Predictive value of detection of serum Cys-C and hs-CRP in cardiovascular adverse events in patients with primary hypertension
YU et al. Detection of serum folate, homocysteine and vitamin B12 in patients with non-small cell lung cancer and its clinical significance

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]